75 related articles for article (PubMed ID: 6288991)
1. Cerebrospinal fluid markers in African Burkitt's lymphoma with central nervous system involvement.
Wallen WC; Biggar RJ; Levine PH; Neequaye J; Nkrumah FK
J Natl Cancer Inst; 1982 Oct; 69(4):787-92. PubMed ID: 6288991
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.
Sutherland JC; Olweny CL; Levine PH; Mardiney MR
J Natl Cancer Inst; 1978 May; 60(5):941-6. PubMed ID: 205665
[No Abstract] [Full Text] [Related]
3. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
[No Abstract] [Full Text] [Related]
4. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
Gunvén P
Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070
[No Abstract] [Full Text] [Related]
6. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
Morrow RH; Sever JL; Henderson BE
Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
[No Abstract] [Full Text] [Related]
7. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
[TBL] [Abstract][Full Text] [Related]
8. Oligoclonal IgG in CSF of patients with African Burkitt's lymphoma.
Wallen WC; Biggar RJ; Levine PH; Iivanainen MV
Arch Neurol; 1983 Jan; 40(1):11-3. PubMed ID: 6848080
[TBL] [Abstract][Full Text] [Related]
9. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies.
Biggar RJ; Nkrumah FK; Henle W; Levine PH
J Natl Cancer Inst; 1981 Mar; 66(3):439-44. PubMed ID: 6259398
[TBL] [Abstract][Full Text] [Related]
10. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
11. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
Gunven P
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
[No Abstract] [Full Text] [Related]
12. EVB-associated immune complexes and recurrent Burkitt's lymphoma.
Gunven P; Klein G; Rosen A; Mukojima T
IARC Sci Publ (1971); 1978; (24 Pt 2):875-82. PubMed ID: 221409
[No Abstract] [Full Text] [Related]
13. Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
Cohen JH; Lenoir GM
Biomed Pharmacother; 1982; 36(5):246-9. PubMed ID: 6301567
[TBL] [Abstract][Full Text] [Related]
14. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
15. Japanese Burkitt's lymphoma: clinicopathological review of 14 cases.
Miyoshi I
Jpn J Clin Oncol; 1983 Sep; 13(3):489-96. PubMed ID: 6315992
[TBL] [Abstract][Full Text] [Related]
16. Serological evidence for active Epstein-Barr virus infection in multifocal choroiditis.
Bhende PS; Biswas J; Madhavan HN
Indian J Pathol Microbiol; 1997 Apr; 40(2):129-31. PubMed ID: 9257497
[TBL] [Abstract][Full Text] [Related]
17. An Epstein-Barr virus-negative B lymphoma cell line (THP-2) from a Burkitt's lymphoma of a Japanese patient.
Tsuchiya S; Yamaguchi Y; Kobayashi Y; Minegishi M; Imaizumi M; Suzuki H; Konno T; Tada K
Tohoku J Exp Med; 1983 Aug; 140(4):429-34. PubMed ID: 6314596
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
20. The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.
Lachmann PJ; Macanovic M; Harkiss GD; Oldroyd RG; Habicht J
Clin Exp Immunol; 1981 Nov; 46(2):250-8. PubMed ID: 6279342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
